Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Changes in Net Assets

v3.25.0.1
Consolidated Statements of Changes in Net Assets - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Balance as of beginning of period (in shares) 84,830,679    
Balance as of beginning of period $ 2,477,399 $ 2,108,586 $ 1,788,846
Public offering of common stock, net of offering costs 122,635 203,683 265,620
Share‑based compensation 18,793 16,520 13,629
Purchase of vested stock for employee payroll tax withholding $ (7,335) $ (5,950) $ (4,943)
Dividend reinvestment (in shares) 721,963 765,427 625,196
Dividend reinvestment $ 35,701 $ 30,719 $ 24,131
Amortization of directors’ deferred compensation 424 434 519
Issuance of restricted stock, net of forfeited shares 0 0 0
Dividends to stockholders (357,859) (305,040) (220,822)
Reclassification for certain permanent book-to-tax differences 0 0 0
Net increase in net assets resulting from operations $ 508,080 $ 428,447 241,606
Balance as of ending of period (in shares) 88,398,713 84,830,679  
Balance as of ending of period $ 2,797,838 $ 2,477,399 $ 2,108,586
Common Stock      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Balance as of beginning of period (in shares) 84,833,002 78,506,816 70,737,021
Balance as of beginning of period $ 848 $ 784 $ 707
Public offering of common stock, net of offering costs (in shares) 2,497,833 5,159,479 6,763,166
Public offering of common stock, net of offering costs $ 25 $ 52 $ 67
Purchase of vested stock for employee payroll tax withholding (in shares) (155,049) (151,058) (116,177)
Purchase of vested stock for employee payroll tax withholding $ (2) $ (1) $ (1)
Dividend reinvestment (in shares) 721,963 765,427 625,196
Dividend reinvestment $ 8 $ 8 $ 6
Issuance of restricted stock, net of forfeited shares (in shares) 502,642 552,338 497,610
Issuance of restricted stock, net of forfeited shares $ 5 $ 5 $ 5
Balance as of ending of period (in shares) 88,400,391 84,833,002 78,506,816
Balance as of ending of period $ 884 $ 848 $ 784
Additional Paid‑In Capital      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Balance as of beginning of period 2,270,549 2,030,531 1,736,346
Public offering of common stock, net of offering costs 122,610 203,631 265,553
Share‑based compensation 18,793 16,520 13,629
Purchase of vested stock for employee payroll tax withholding (7,333) (5,949) (4,942)
Dividend reinvestment 35,693 30,711 24,125
Amortization of directors’ deferred compensation 424 434 519
Issuance of restricted stock, net of forfeited shares (5) (5) (5)
Dividends to stockholders 717 623 466
Reclassification for certain permanent book-to-tax differences (46,956) (5,947) (5,160)
Balance as of ending of period 2,394,492 2,270,549 2,030,531
Total Undistributed Earnings      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Balance as of beginning of period 206,002 77,271 51,793
Dividends to stockholders (358,576) (305,663) (221,288)
Reclassification for certain permanent book-to-tax differences 46,956 5,947 5,160
Net increase in net assets resulting from operations 508,080 428,447 241,606
Balance as of ending of period $ 402,462 $ 206,002 $ 77,271